Langerhans’ cell histiocytosis and haemophagocytic lymphohistiocytosis in an elderly patient
✍ Scribed by D Ioannidou; K Krasagakis; J Panayiotidis; M Stefanidou; M Alexandrakis; A Tosca
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 133 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0926-9959
No coin nor oath required. For personal study only.
✦ Synopsis
ABSTRACT
We present a case of a 78‐year‐old man suffering from a chronic psoriasiform eruption, with rapid deterioration over the previous 8 weeks. Langerhans’ cell histiocytosis with skin and bone involvement was diagnosed, and there was evidence of liver and lung dysfunction. The patient was treated with prednisolone and etoposide, and initially experienced a partial improvement. Three weeks later, haemophagocytic lymphohistiocytosis and subsequently a large pulmonary abscess with sepsis attributed to opportunistic gram‐negative enterobacteriaceae Serratia marcescens developed, and the patient died. The present case of Langerhans’ cell histiocytosis is of particular interest because of the previously unreported development of haemophagocytic lymphohistiocytosis in the elderly population.
📜 SIMILAR VOLUMES
received VBL / HDMP; at last follow-up, 1 patient was in CCR 8 months after Biotechnology and Hematology, University ''La completion of therapy, and the other developed progressive disease 11 months Sapienza,'' Rome, Italy. later. The third patient was treated with interferon (IFN) and at last foll
We present an elderly patient with mantle cell leukemia who was successfully treated with low-dose cyclophosphamide (CY). A 76-year-old female was diagnosed as mantle cell leukemia based on abnormal lymphocytosis and splenomegaly without lymphadenopathy. She was orally treated with 50 mg of CY daily
## Abstract ## Background Current theory on the etiology of Langerhans cell histiocytosis (LCH), formerly Histiocytosis‐X, is that abnormality(ies) of the immune system are responsible for dysregulation of Langerhans cells (LC) in patients' lesions. Among the known abnormalities in LCH patients ar
## Abstract We report a case of an EBV‐associated high grade B‐cell lymphoproliferative disorder occurring in the synovial membrane of an elderly patient with gout arthropathy. The EBV‐infected B‐cells displayed a pattern of viral gene expression (EBNA2^+^/LMP1^+^) typically seen during primary EBV